Trademark: 79289157
Word
LIPOLYTIC 37.5 60 CAPSULES TRI PHARMA COMPANY
Status
Registered
Status Code
700
Status Date
Tuesday, June 22, 2021
Serial Number
79289157
Registration Number
6391873
Registration Date
Tuesday, June 22, 2021
Mark Type
3000
Filing Date
Tuesday, April 21, 2020
Published for Opposition
Tuesday, April 6, 2021

Trademark Owner History
TRI-PHARMA Limited Liability Company - Original Registrant

Classifications
39 Delivery of goods; delivery of goods by mail order; packaging of goods; wrapping of goods in the nature of gift wrapping; storage of goods
5 dietetic substances adapted for medical use in the nature of dietetic foods adapted for medical use; buckthorn barks for pharmaceutical purposes; biological preparations for medical purposes for the treatment of obesity; albuminous foodstuffs for medical purposes in the nature of medicated supplements with vegetable raw materials containing Caralluma fimbriata
35 public opinion polling; conducting marketing studies; marketing services; commercial intermediation services, namely, business management consulting and advisory services; web indexing for commercial or advertising purposes, namely, compiling indexes of information; presentation of goods on communication media, for retail purposes in the nature of providing television home shopping services in the field of general consumer merchandise; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; direct mail advertising services; advertising services
The mark consists of the stylized wording "LIPOLYTIC" where the "L" is blue and "IPOLYTIC" is in gray font. To the left of the wording are four vertical lines of various widths, from thin to thickest, that are different shades of blue. Under the wording "LIPOLYTIC" is the numbers "37.5" in white on a blue rectangle. Under the "37.5", is the wording "60 CAPSULES" in blue. Under this wording is a blue horizontal line. Under the line, is the stylized wording "TRI PHARMA COMPANY" in black font, to the right of a stylized gray triangle. The entire image is on a white background.
LIPOLYTIC THIRTY SEVEN . FIVE SIXTY CAPSULES TRI PHARMA COMPANY; LIPOLYTIC THREE SEVEN POINT FIVE SIX ZERO CAPSULES TRI PHARMA COMPANY
The color(s) blue, black, gray, and white is/are claimed as a feature of the mark.
"LIPOLYTIC", "37.5", "60 CAPSULES" AND "PHARMA COMPANY"

Trademark Events
Mar 12, 2022
Change Of Name/Address Rec'd From Ib
Dec 13, 2021
Final Decision Transaction Processed By Ib
Oct 13, 2021
Generic Madrid Transaction Sent To Ib
Oct 13, 2021
Generic Madrid Transaction Created
Sep 22, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jun 22, 2021
Registered-Principal Register
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Published For Opposition
Apr 5, 2021
Notification Processed By Ib
Mar 17, 2021
Notification Of Possible Opposition Sent To Ib
Mar 17, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Mar 2, 2021
Approved For Pub - Principal Register
Mar 1, 2021
Teas/Email Correspondence Entered
Mar 1, 2021
Correspondence Received In Law Office
Mar 1, 2021
Teas Request For Reconsideration Received
Feb 25, 2021
Notification Of Final Refusal Emailed
Feb 25, 2021
Final Refusal E-Mailed
Feb 25, 2021
Final Refusal Written
Feb 2, 2021
Teas/Email Correspondence Entered
Feb 2, 2021
Correspondence Received In Law Office
Feb 1, 2021
Assigned To Lie
Oct 23, 2020
Teas Response To Office Action Received
Aug 30, 2020
Refusal Processed By Ib
Aug 11, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Aug 11, 2020
Refusal Processed By Mpu
Jul 18, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Jul 17, 2020
Non-Final Action Written
Jul 14, 2020
Application Filing Receipt Mailed
Jul 13, 2020
Assigned To Examiner
Jul 10, 2020
New Application Office Supplied Data Entered In Tram
Jul 9, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24